Airflow Obstruction in Adults with Williams Syndrome and Mice with Elastin Insufficiency.

Williams Beuren syndrome air trapping obstructive pulmonary disease pulmonary function tests

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
10 Jun 2022
Historique:
received: 18 04 2022
revised: 05 06 2022
accepted: 07 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Williams−Beuren syndrome (WS) results from the deletion of 25−27 coding genes, including elastin (ELN), on human chromosome 7q11.23. Elastin provides recoil to tissues; emphysema and chronic obstructive pulmonary disease have been linked to its destruction. Consequently, we hypothesized that elastin insufficiency would predispose to obstructive features. Twenty-two adults with WS (aged 18−55) and controls underwent pulmonary function testing, 6 min walk, and chest computed tomography (CT). Lung and airspace dimensions were assessed in Eln+/− and control mice via microCT and histology. The forced expiratory volume in 1 s (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) were lower in adults with WS (p < 0.0001 and p < 0.05, respectively). The FEV1/FVC ratio was more frequently below the lower limit of normal in cases (p < 0.01). The ratio of residual volume to total lung capacity (RV/TLC, percent predicted) was higher in cases (p < 0.01), suggesting air trapping. People with WS showed reduced exercise capacity (p < 0.0001). In Eln+/− mice, ex vivo lung volumes were increased (p < 0.0001), with larger airspaces (p < 0.001). Together these data show that elastin insufficiency impacts lung physiology in the form of increased air trapping and obstruction, suggesting a role for lung function monitoring in adults with WS.

Identifiants

pubmed: 35741248
pii: diagnostics12061438
doi: 10.3390/diagnostics12061438
pmc: PMC9221558
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIH HHS
ID : ZIA HL006212
Pays : United States

Références

J Invest Dermatol. 2005 Jun;124(6):1193-9
pubmed: 15955094
Am J Respir Cell Mol Biol. 2005 Oct;33(4):355-62
pubmed: 16081882
J Child Neurol. 2002 Apr;17(4):269-71
pubmed: 12088082
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Biol Chem. 2011 Dec 30;286(52):44926-36
pubmed: 22049077
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Nat Rev Dis Primers. 2021 Jun 17;7(1):42
pubmed: 34140529
BMC Pulm Med. 2019 Nov 9;19(1):206
pubmed: 31706309
Case Rep Pediatr. 2017;2017:3480980
pubmed: 28626595
Nature. 1998 May 21;393(6682):276-80
pubmed: 9607766
Am J Med Genet A. 2021 Feb;185(2):390-396
pubmed: 33174385
Am J Med Genet A. 2014 Sep;164A(9):2217-25
pubmed: 24920525
Am J Med Genet A. 2017 Aug;173(8):2235-2239
pubmed: 28574231
Am J Respir Cell Mol Biol. 2009 Jun;40(6):751-5
pubmed: 19029017
Pediatr Cardiol. 2005 Nov-Dec;26(6):827-31
pubmed: 15990952
Circ Cardiovasc Imaging. 2018 Dec;11(12):e007653
pubmed: 30525986
Matrix Biol. 2019 Nov;84:31-40
pubmed: 31669522
J Clin Invest. 1998 Nov 15;102(10):1783-7
pubmed: 9819363
Matrix Biol. 2018 Nov;73:6-20
pubmed: 29331337
Age (Dordr). 2009 Dec;31(4):305-25
pubmed: 19588272
J Clin Invest. 1991 May;87(5):1828-34
pubmed: 2022748
Matrix Biol. 2018 Oct;71-72:144-160
pubmed: 29501665
Am J Med Genet A. 2010 Mar;152A(3):653-6
pubmed: 20186780
Circulation. 2013 May 28;127(21):2125-34
pubmed: 23716381
Circulation. 1962 Dec;26:1235-40
pubmed: 13967885
J Vis Exp. 2020 Jun 20;(160):
pubmed: 32628170
Am J Physiol Lung Cell Mol Physiol. 2007 Mar;292(3):L778-87
pubmed: 17142349
Circ Cardiovasc Imaging. 2008 Nov;1(3):235-43
pubmed: 19808548
Am J Med Genet A. 2012 Aug;158A(8):2053-4
pubmed: 22740173
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151

Auteurs

Elise K Kronquist (EK)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Maninder Kaur (M)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Leah M Gober (LM)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Russell H Knutsen (RH)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Yi-Ping Fu (YP)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Zu-Xi Yu (ZX)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Danielle R Donahue (DR)

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20824, USA.

Marcus Y Chen (MY)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Sharon Osgood (S)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Neelam Raja (N)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Mark D Levin (MD)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Amisha Barochia (A)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Beth A Kozel (BA)

National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Classifications MeSH